Nutley, NJ, United States of America

Rosalinda Syto

This inventor holds 2 USPTO granted patents. Top assignee: Schering Corporation. Active years: 2010-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rosalinda Syto. Retrieved from https://idiyas.com/inventor/rosalinda-syto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Rosalinda Syto

Introduction

Rosalinda Syto is an accomplished inventor based in Nutley, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides related to human protein kinase B gamma (AKT3). With a total of 2 patents, her work has implications for cancer research and therapeutic development.

Latest Patents

Her latest patents include the invention of a kinase domain polypeptide of human protein kinase B gamma (AKT3). This invention provides, in part, AKT3 polypeptides and methods of use, along with nucleic acids encoding these polypeptides. Additionally, she has developed polynucleotides encoding polypeptide fragments of protein kinase B gamma (AKT3), which also includes methods for screening for AKT3 inhibitors.

Career Highlights

Rosalinda Syto is currently employed at Schering Corporation, where she continues to advance her research in biotechnology. Her work has been pivotal in understanding the mechanisms of AKT3 and its potential as a target for therapeutic intervention.

Collaborations

She has collaborated with notable colleagues, including Andrew Joseph Prongay and Thierry Olivier Fischmann, to further her research and innovations in the field.

Conclusion

Rosalinda Syto's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in cancer treatment and research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…